| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 6e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.002 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |